Modern Treatment of Diabetes
We recommend
Přínos včasně zahájené léčby metforminem s prodlouženým účinkem a bisoprololem na snížení KV rizika – kazuistika
Včasná diagnostika a intenzivní léčba rizikových faktorů (RF) kardiovaskulárního onemocnění (KVO) s sebou přináší benefit ve smyslu snížení pravděpodobnosti jeho výskytu. Nakupení těchto faktorů (hypertenze, nadváha či obezita, hyperurikémie, porucha metabolismu lipidů a glycidů – prediabetes nebo diabetes mellitus) u jednoho pacienta potom definujeme jako metabolický syndrom, který představuje velmi významné KV riziko. Následující kazuistika ilustruje efektivní možnost jeho snížení.
Current findings on the treatment of gestational diabetes and DM2 in pregnancy with metformin
Recent reviews have shown that metformin is a safe alternative to insulin in the treatment of…
Meta-analysis of Efficacy and Safety of Antidiabetics in Treating Gestational DM
What efficacy and safety do insulin, metformin, or the sulfonylurea derivative glibenclamide…
Articles on this topic
Less is Sometimes More – How Generic Substitution Can Affect Patient Adherence
It is undisputed that the use of generic drugs saves the healthcare system significant costs.…
Limits of Glycated Hemoglobin and the Importance of Other Glycated Proteins
Glycated hemoglobin is a gold standard in the diagnosis and management of diabetes treatment.…
Effects of Metformin on the Cardiovascular System of Patients with Diabetes, but Also Without It
Diabetes mellitus (DM) is considered an independent risk factor for the development of…
The Future and Prospects of Type 2 Diabetes Therapy: Can We Fully Cure It with Endoscopy or Genetics?
Diabetes mellitus (DM) cannot be cured, but it can be successfully treated... Will we rewrite…
Metformin − A Proven Helper That Effectively Protects the Heart of Diabetics
Metformin is one of the first-line medications for patients with type 2 diabetes. In addition…
Glucagon for Intranasal Application Newly Available Also in the Czech Republic
Intramuscular administration of glucagon was until recently the only option for acute…
Side Effects of Metformin: It's Not Just a Nocebo Effect?
If we were to name medications that have the greatest significance from a population…
Prevalence of Diabetics Among Patients with COVID-19 and the Impact of DM on the Course of Infection
Italian authors published the results of a meta-analysis of studies at the end of March,…
Metformin and Cardiovascular Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease
Diabetes mellitus is a serious chronic disease that, due to its ever-increasing prevalence,…
Are SGLT2 Inhibitors Only Suitable for the Treatment of Diabetes?
SGLT2 inhibitors, or gliflozins, are effective antidiabetic drugs that have shown…
Subscribe
E-courses on this topic
Most read on this topic
- Side Effects of Metformin: It's Not Just a Nocebo Effect?
- Metformin in Pregnancy and Its Safety Profile
- Limits of Glycated Hemoglobin and the Importance of Other Glycated Proteins
- Glucagon for Intranasal Application Newly Available Also in the Czech Republic
- Metformin − A Proven Helper That Effectively Protects the Heart of Diabetics
- XR vs. IR Form of Metformin − It’s Not Just About Gastrointestinal Tolerability
Interesting links